RaySearch Laboratories AB (publ) (STO:RAY.B)
Sweden · Delayed Price · Currency is SEK 190.70
-0.80 (-0.42%)
Aug 12, 2026, 10:09 AM CET
RaySearch Laboratories AB Market Cap
RaySearch Laboratories AB has a market cap or net worth of 6.57 billion as of August 11, 2026. Its market cap has decreased by -36.27% in one year.
Market Cap
6.57B
Enterprise Value
6.50B
Revenue
1.30B
Ranking
n/a
PE Ratio
29.30
Stock Price
190.70
ChartMarket Cap Chart
Since October 30, 2003, RaySearch Laboratories AB's market cap has increased from 189.23M to 6.57B, an increase of 3,369.34%. That is a compound annual growth rate of 16.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 6.43B | -17.68% |
| Dec 30, 2025 | 7.82B | 5.56% |
| Dec 30, 2024 | 7.41B | 139.20% |
| Dec 29, 2023 | 3.10B | 32.79% |
| Dec 30, 2022 | 2.33B | 20.35% |
| Dec 30, 2021 | 1.94B | -31.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 153.29B |
| Getinge AB | 65.10B |
| Sectra AB | 52.25B |
| Camurus AB | 37.01B |
| Xvivo Perfusion AB | 9.61B |
| MedCap AB | 8.26B |
| Dynavox Group AB | 8.07B |
| Synsam AB | 7.76B |